Waisman Center investigator David Gamm, MD, PhD, and Waisman affiliate Kris Saha, PhD, have published a proof-of-concept method to correct Best disease – an inherited form of macular degeneration that causes blindness, and that is …
Stem Cells
Grant awarded for eye disease research
A big congratulations to researcher Kim Edwards and Waisman investigator David Gamm, MD, PhD, on winning the inaugural Randy Wheelock Research Award. Gamm is also an associate professor of ophthalmology and visual science as well as the director of the McPherson Eye Research Institute.
Improved technique illuminates fragile X protein
Researchers at the Waisman Center made a significant step in understanding the function of a specific protein, FMR1, whose absence causes fragile X syndrome, or FXS. Waisman investigators Xinyu Zhao, PhD, and Anita Bhattacharyya, PhD, with research associate Meng Li, published their paper “Identification of FMR1-regulated molecular networks in human neurodevelopment” in the March issue of the journal Genome Research.
Newly identified cellular trash removal program helps create new neurons
New research by University of Wisconsin–Madison scientists reveals how a cellular filament helps neural stem cells clear damaged and clumped proteins, an important step in eventually producing new neurons.
May is ALS Awareness Month
May is #ALSAwarenessMonth and Waisman investigator Su-Chun Zhang, MD, PhD, uses stem cells to uncover the cause of ALS with the hope of developing treatments and therapies.
‘This can be changed’: Verona family carries on daughter’s fight to end vision diseases
A recent story on Channel 3000 highlights the efforts by the family of Kenzi Valentyn to raise money for vision research in their daughter’s name. Waisman investigator David Gamm focuses on using stem cells to …
Lab to Clinic Video: David Gamm, MD, PhD
David Gamm, director of the McPherson Eye Research Institute, and Forward Bio Institute director Bill Murphy explain how stem cell scientists at UW–Madison are working with industry to put scientific breakthroughs on the path to …
Waisman’s stem cell research into Down syndrome gives family hope
It’s not a cure for Down syndrome that Dave Witte and Cristina Delgadillo want for their 5-year-old daughter. “Olivia is our daughter and we love her, and we love her because of who she is. …
New gene editing tool driving stem cell services and discovery
A new gene editing service provides researchers on campus with genetically engineered pluripotent stem cell lines derived using CRISPR-Cas9. The UW-Madison iPSC Reprogramming and Human Stem Cell Gene Editing Service is co-operated by the Waisman …
Five questions for Su-Chun Zhang, forger of stem cells
Su-Chun Zhang, a Waisman Center investigator, was the first person in the world to craft human brain cells both from human embryonic stem (ES) cells and later from induced pluripotent (iPS) cells. In a recent interview …